Bahir Dar Child Development Study, Ethiopia
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Oct 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Bahir Dar Child Development Study is a research project taking place in Ethiopia, aimed at understanding how children develop from 6 months to 5 years old. The study will look at how children's brains grow, their social and behavioral skills, and what factors in their lives—like their home environment and their mother's mental health—affect their development. To gather this information, researchers will use brain scans, blood tests, and various child assessments to measure things like thinking, communication, and preparation for school.
To participate, children must be healthy and living in Bahir Dar, with parents willing to attend clinic visits. Eligible children will be between 6 months and 5 years old, and they should not have severe health or developmental issues. Families can expect to engage in fun activities with their children that help assess different skills, while also answering questions about their home life. This study is important to help understand child development in this community and could lead to better support for families in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children living in Bahir Dar town with parents who are willing and able to travel to Felege Hiwot Regional Hospital clinic for study visits
- • Healthy child without active clinical symptoms/complaints
- • Child within specified age ranges for each cohort/group (+/- 2 months)
- Exclusion Criteria:
- • Child born with a severe congenital birth defect or hypoxic ischemic encephalopathy (birth asphyxia) per maternal report
- • Severe developmental or behavioral disorder per maternal report
- • Severe illness/clinical signs or symptoms of illness based on maternal and child report (including vomiting, headache, or seizures)
- • Plans to move out of catchment area in less than 1 year
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bahir Dar, Addis, Ethiopia
Patients applied
Trial Officials
Anne C Lee, MD, MPH
Principal Investigator
Brigham and Women's Hospital
Yemane Berhane, MD, PhD
Principal Investigator
Addis Continental Institute of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported